David Hochman

David Hochman

Vorstandsvorsitzender bei ORCHESTRA BIOMED HOLDINGS, INC.

Vermögen: 6 Mio $ am 31.05.2026

50 Jahre
Health Technology
Finance
Health Services

Profil

David P.
Hochman
is the founder of OPKO Biologics Ltd. (2001), Prescient Medical, Inc. (2004), Caliber Therapeutics LLC (2009), FreeHold Surgical LLC (2011), BackBeat Medical LLC (2011), Corbus Pharmaceuticals Holdings, Inc. (2013), Orchestra BioMed, Inc. (2018), and Orchestra Biomed Holdings, Inc. (2020).
Titles held at these companies included Director at OPKO Biologics Ltd. (2005–2007), Director at Caliber Therapeutics LLC (2009–2018), Director at FreeHold Surgical LLC (2011–2018), Director at BackBeat Medical LLC (2018), Director at Corbus Pharmaceuticals Holdings, Inc. (2013–2020), Chairman & Chief Executive Officer at Orchestra BioMed, Inc. (2018–present), and Chairman & Chief Executive Officer at Orchestra Biomed Holdings, Inc. (2020–present).
Current jobs include Chairman at Motus G.I.
Medical Technologies Ltd. (2011–present), Director at Corbus Pharmaceuticals, Inc., Director at Aids Action Foundation, and President & Director at Mollie Parnis Livingston Foundation, Inc.Former jobs include Chief Executive Officer at Spencer Trask Edison Partners LLC (1997–2006), Vice Chairman at Naked Brand Group, Inc. (2014–2017), Chairman at Vital Access Corp.
(2008–2017), Director at Orchestra Therapeutics, Inc., Managing Director at Augment Securities, Inc. (2005), Director at Journey Health, Inc. (Virginia) (2013–2018), Director at Citizens Committee for New York City (1999–2019), Director at Adgero Biopharmaceuticals Holdings, Inc. (2015–2020), Independent Director at Motus GI Holdings, Inc. (2023), Advisor at Idera Pharmaceuticals, Inc., Advisor at Health Dialog Services Corp., Managing Partner at Orchestra Medical Ventures LLC, and President at Accelerated Technologies, Inc. (Texas) (2009–2019).
Education includes undergraduate degree from the University of Michigan, conferred in 1997.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
10.06.2026 1’506’085 ( 2.79% ) 6 Mio $ 31.05.2026

Aktive Positionen von David Hochman

UnternehmenPositionBeginn
ORCHESTRA BIOMED HOLDINGS, INC. Vorstandsvorsitzender 25.05.2020
Direktor/Vorstandsmitglied -
Vorstandsvorsitzender 01.05.2018
Vorsitzender 01.09.2011
Mollie Parnis Livingston Foundation, Inc.
Präsident -
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von David Hochman

UnternehmenPositionEnde
MOTUS GI HOLDINGS, INC. Vorsitzender 13.04.2023
CORBUS PHARMACEUTICALS HOLDINGS, INC. Gründer 11.09.2020
Direktor/Vorstandsmitglied 01.01.2020
░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░ ░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von David Hochman im Detail an

Ausbildung von David Hochman

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

81

Beziehungen ersten Grades

26

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen26

Finance

Health Technology

Health Services

Finance

Distribution Services

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Health Services

Consumer Services

Finance

Health Technology

Producer Manufacturing

Spencer Trask Edison Partners LLC

Health Technology

Electronic Technology

Commercial Services

Mollie Parnis Livingston Foundation, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. David Hochman
-40 %: Exklusive Verlängerung
T
:
:
PROFITIEREN SIE JETZT